(Q50115867)

25 February 2018

title

Intradermal delivery for vaccine dose sparing: overview of current issues. (English)

1 reference

25 February 2018

author name string

Darin Zehrung

series ordinal

1

1 reference

25 February 2018

Courtney Jarrahian

series ordinal

2

1 reference

25 February 2018

Amy Wales

series ordinal

3

1 reference

25 February 2018

language of work or name

English

0 references

publication date

20 November 2012

1 reference

25 February 2018

published in

Vaccine

1 reference

25 February 2018

volume

31

1 reference

25 February 2018

issue

34

1 reference

25 February 2018

page(s)

3392-3395

1 reference

25 February 2018

Skin immune sentinels in health and disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.021

Intradermal delivery of vaccines: potential benefits and current challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.021

Intradermal fractional dose inactivated polio vaccine: a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.021

Current evidence on intradermal influenza vaccines administered by Soluvia™ licensed micro injection system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.021

Fractional doses of inactivated poliovirus vaccine in Oman

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.021

Randomized controlled study of fractional doses of inactivated poliovirus vaccine administered intradermally with a needle in the Philippines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.021

Intradermally administered yellow fever vaccine at reduced dose induces a protective immune response: a randomized controlled non-inferiority trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.021

Reduced intradermal test dose of yellow fever vaccine induces protective immunity in individuals with egg allergy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.021

Safety and immunogenicity of modified vaccinia Ankara (ACAM3000): effect of dose and route of administration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.021

Immunogenicity, large scale safety and lot consistency of an intradermal influenza vaccine in adults aged 18-60 years: Randomized, controlled, phase III trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.021

Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.021

Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.021

Rabies preexposure prophylaxis with human diploid cell rabies vaccine: a dose-response study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.021

Economical multiple-site intradermal immunisation with human diploid-cell-strain vaccine is effective for post-exposure rabies prophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.021

Reducing the cost of post-exposure rabies prophylaxis: efficacy of 0.1 ml PCEC rabies vaccine administered intradermally using the Thai Red Cross post-exposure regimen in patients severely exposed to laboratory-confirmed rabid animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.021

Revision of the Thai Red Cross intradermal rabies post-exposure regimen by eliminating the 90-day booster injection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.021

Incremental costs of introducing jet injection technology for delivery of routine childhood vaccinations: comparative analysis from Brazil, India, and South Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.021

The real cost of rabies post-exposure treatments.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.021

Evaluation of cost-effective strategies for rabies post-exposure vaccination in low-income countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.021

Intradermal pre-exposure rabies vaccine elicits long lasting immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.021

Single versus multi-dose vaccine vials: an economic computational model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.021

Willingness to vaccinate or get vaccinated with an intradermal seasonal influenza vaccine: a survey of general practitioners and the general public in France and Germany.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.021

Improving the reach of vaccines to low-resource regions, with a needle-free vaccine delivery device and long-term thermostabilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.11.021

10.1016/J.VACCINE.2012.11.021

7 January 2021

Identifiers

DOI

1 reference

25 February 2018

1 reference

25 February 2018